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Abstract
Background: Since 1998, the U.S. Armed Forces has used the mandatory Pre-Deployment Health
Assessment (PreDHA) screening questionnaire as a means of assessing the health and suitability of
U.S. service members for deployment. Limited data exists to quantify the validity of the self-
reported PreDHA. This study was conducted to assess the validity of self-reporting in PreDHA to
identify deployed service members who have had a recent mental health disorder diagnosis.
Methods: A retrospective cohort study was conducted on 15,195 U.S. service members deployed
in support of combat and reconstruction operations in Afghanistan. The Defense Medical
Surveillance System (DMSS), the DoD's longitudinal medical surveillance database, was queried to
identify cases among the cohort with a recent diagnosis of a pertinent mental health disorder and
to obtain those subjects' responses to the PreDHA.
Results: Of the study cohort, 11,179 (73.6%) subjects had a PreDHA available within the DMSS at
the time of analysis. A total of 615 subjects (4.0%) had one or more mental health disorder
diagnoses during the pre-deployment period. Out the 615 subjects with diagnosed mental health
disorders, 465 had a PreDHA. Among these, only 224, not quite half, answered in the affirmative
to the PreDHA question: "During the past year, have you sought counseling or care for your mental
health?"
Conclusion: This study demonstrates that the self-reported PreDHA has low validity for
identifying service members with diagnosed mental health disorders. The development of
electronic decision-support systems which automatically screen electronic health records to
identify high-risk service members may prove a valuable component of improved pre-deployment
screening processes.
Background
Within the U.S. military, commanders and medical staff
have a shared obligation to ensure that service members
under their command or care are free of potentially dis-
qualifying or significant mental health disorders that
might affect their suitability for and stability during pro-
longed deployments. Pre-deployment screening programs
that identify service members with a recent history of
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to the existing multilayered process of screening and selec-
tion that occurs during accession into the military [1] and
during training and service prior to deployment [2].
The Pre-Deployment Health Assessment (PreDHA)
screening questionnaire was introduced by the U.S.
Department of Defense (DoD) in 1998 as a means of
assessing the health and suitability of service members for
deployment [3-5]. According to current DoD policies,
PreDHAs are to be completed by all service members
deploying to land-based operations for 30 days or longer
[6], and are to be completed within the 60 days prior to
the expected date of deployment [7]. Once completed,
PreDHAs are forwarded to the Armed Forces Health Sur-
veillance Center (AFHSC) for inclusion in the Defense
Medical Surveillance System (DMSS), the DoD's longitu-
dinal medical surveillance database [8]. The DMSS inte-
grates information on pertinent service member
demographics, inpatient and outpatient medical diag-
noses at military and civilian medical facilities, and other
pertinent health data [5,8], which permits robust epide-
miological analyses of health conditions associated with
military service.
Since the development of the PreDHA, concerns over the
rising mental health consequences of the conflicts in Iraq
and Afghanistan have been well described [9-17]. Low-
ered standards for acceptance of recruits into the military
and repeated deployments have combined to significantly
increase the prevalence of mental health disorders among
U.S. military personnel, including ADHD [18], PTSD
[9,14,15,17], anxiety [9], and depression [9,17,19]. As a
result, the risk is increased that service members with dis-
qualifying mental health disorders will be inappropriately
deployed, and that service members will be prescribed
and exposed to medications such as mefloquine (a com-
monly used anti-malarial), whose contraindications
include a history of certain mental health disorders [20].
It has been noted that screening programs are often devel-
oped and implemented with minimal evidence as to their
efficacy [21]. Between January 2003 and July 2007, over
1,705,787 PreDHA had been administered to deploying
U.S. military personnel [5], but to date no published stud-
ies have been performed to quantify either the validity or
utility of their administration, or to determine how the
potential benefits of administering the PreDHA compare
to the possible psychological, financial and opportunity
costs of implementing the PreDHA screening program [4].
To assess the validity of self-report among service mem-
bers completing PreDHA, and to quantify the test charac-
teristics of selected questions on the PreDHA for
identifying deployed service members with a recent men-
tal health disorder diagnosis, a retrospective cohort study
was performed on a large group of U.S. service members
deployed to Afghanistan in 2007.
Methods
Data Sources, Inclusion and Exclusion Criteria
The U.S. military collects and records pertinent demo-
graphic information on service members deploying to
combat zones and to other areas of the world in support
of contingency operations in a database known as the
Defense Theater Accountability System (DTAS). In sup-
port of this study, DTAS was queried for a listing of all U.S.
military personnel deployed in support of combat and
reconstruction operations in Afghanistan as members of
the North Atlantic Treaty Organization (NATO) Interna-
tional Security and Assistance Force (ISAF) [22] as of a ref-
erence date in early 2007, and this listing was provided to
staff at AFHSC for further data queries using the DMSS.
To ensure consistency of demographic data, service mem-
bers who did not have demographic records available in
the DMSS were excluded from analysis. To improve the
completeness of data available for analysis, service mem-
bers with fewer than 30 days of continuous deployment as
of the reference date were also excluded. Among remain-
ing service members, the date of the last PreDHA com-
pleted and available for analysis within the DMSS was
determined, and if there was a record of a PreDHA com-
pleted after the DTAS date of deployment, the DTAS
deployment date was deemed questionable and the serv-
ice member was excluded from analysis. All remaining
service members comprised the study cohort.
Demographic and Military Service Data
For each member of the study cohort, the DMSS was que-
ried to determine basic demographic and military service
data, including gender, number of prior deployments,
and military occupational specialty (combat vs. non-com-
bat). Age was calculated as of the reference date.
Mental Health History
For each member of the study cohort, the DMSS was que-
ried for evidence of International Classification of Dis-
eases, 9th Edition, Clinical Modification (ICD-9CM) [23]
coded diagnoses of pertinent inpatient or outpatient men-
tal health diagnoses, to include major depressive disorder
(ICD-9CM 296.2-296.3), adjustment disorder with
depressed mood (ICD9-CM 309.0 and 309.28), pro-
longed depressive reaction (ICD-9CM 309.1), dysthymic
disorder (ICD-9CM 300.4), depression (ICD-9CM 311),
cyclothymic disorder (ICD-9CM 301.13), generalized
anxiety disorder (ICD-9CM 300.02), nonorganic psycho-
ses and schizophrenia (ICD-9CM 298 and 295), bipolar
and manic disorders (ICD-9CM 296.0-296.1, 296.3-
296.8), obsessive-compulsive disorder (ICD-9CM 300.3),
panic disorder, with or without agoraphobia (ICD-9CM
300.01, 300.21), attention-deficit disorders, with or with-Page 2 of 11
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sion and factitious disorders (ICD-9CM 300.1),
delusional disorders (ICD-9CM 297), and post-traumatic
stress disorders (ICD-9CM 309.81). Sub-coded ICD-9CM
diagnoses (i.e. those with additional digits of precision)
were included. Excluded from analysis were drug and
alcohol-related disorders, transient or poorly-defined
conditions, phobic disorders, personality disorders, sex-
ual and gender identity disorders, and somatoform diag-
noses. A recent mental health disorder diagnosis was
defined as one or more pertinent primary or secondary
ICD-9CM codes recorded in the full year prior to the
deployment date.
Pre-Deployment Health Assessments
To permit analysis of data from study cohort subjects who
might have experienced delays in deployment, all PreD-
HAs within the 90 days prior to the DTAS deployment
date and available in DMSS at the time of analysis were
evaluated for pertinent subject and health care provider
responses.
Pertinent subject responses included those to three ques-
tions: question #7 "During the past year, have you sought
counseling or care for your mental health?"; question #2 "Do
you have any medical or dental problems?"; and question #8
"Do you currently have any questions or concerns about your
health?". Pertinent health care provider responses
included those to two questions: "referral indicated" and
"final medical disposition". Responses considered pertinent
included a referral for "combat/operational stress reaction",
"family problems", "fatigue, malaise, multisystem complaint",
"mental health", and "neurologic" problems, or a final med-
ical disposition of "not deployable". Pages 1 and 2 of the
current two-page PreDHA instrument are enclosed as Fig-
ure 1 and Figure 2, respectively; with questions systemati-
cally evaluated for this analysis outlined in red.
Statistical Analysis and Methods
The demographic characteristics of the study cohort and
those with a pre-deployment mental health disorder diag-
nosis were compared by Chi-square test across demo-
graphic strata, and odds ratios (OR) and 95% confidence
intervals (CI) were calculated for dichotomous strata.
Numbers of subjects with recent mental health disorder
diagnosis by ICD-9CM coded diagnosis category were
determined. Numbers of subjects in the study cohort and
with a recent mental health disorder diagnosis with avail-
able PreDHAs within 90 days prior to the DTAS deploy-
ment date were compared by Chi-square test. Among
those with a recent mental health disorder diagnosis, the
OR for the presence of multiple available PreDHAs within
90 days of deployment was assessed.
To evaluate the test characteristics of the PreDHA, subjects
with one or more PreDHA completed in the 90 days prior
to deployment were stratified by presence of recent men-
tal health disorder diagnosis, and the presence of perti-
nent responses to questions from the most recent PreDHA
were assessed to calculate the odds ratio (OR) and
"number needed to screen" (NNS) for each. In contrast to
other uses of this statistic [21], for this study the NNS was
defined as the number of subjects needed to be screened
with the PreDHA in the 90 days prior to deployment to
obtain a positive response to one or more pertinent ques-
tions on the most recent PreDHA in the presence of a
recent mental health disorder diagnosis. Additional odds
ratios were assessed comparing presence of referral or
non-deployable status and positive responses to subject-
reported data. Data manipulation was performed using
SAS 9.1 [24]. Odds ratios and 95% confidence intervals
were obtained via the Cornfield approximation [25] using
Stata 8.0.
Ethical Considerations
This analysis was conducted by a duly constituted public
health authority to evaluate the effectiveness of military
medical screening programs and policies. Data were
requested from AFHSC under military command
approval, with analysis performed consistent with Depart-
ment of Defense Directives (DoDD) 6590.2 and DoDD
6490.02E and as non-research exempt from Institutional
Review Board (IRB) requirements in accordance with
United States Code of Federal Regulations (CFR) section
38 CFR 16 ("The Common Rule"). Identified health data
were securely transmitted, processed and retained on data
systems compliant with DoD information assurance poli-
cies.
Results
Subject Demographics and Mental Health History
A list of 18,733 U.S. service members was provided to
AFHSC, and after application of exclusion criteria, the
final study cohort comprised 15,195 subjects. A total of
615 subjects (4.0%) had one or more mental health dis-
order diagnoses in the year prior to deployment. Females
had over twice the odds of having a recent mental health
disorder diagnosis (OR = 2.26, 95% CI 1.82-2.80) as
males (P < 0.001, χ2 = 58.09). Subjects with one or more
prior deployments had significantly greater odds of hav-
ing a recent mental health disorder diagnosis (OR = 1.44,
95% CI 1.22-1.70) as those without (P < 0.001, χ2 =
19.18). Those in non-combat occupations had signifi-
cantly greater odds of having a recent mental health disor-
der diagnosis (OR = 1.33, 95% CI 1.09-1.62) as those in
combat occupations (P = 0.006, χ2 = 7.69). There were no
significant differences between the study cohort and those
with a recent mental health disorder diagnosis by age cat-Page 3 of 11
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Pre-Deployment Health Assessment (PreDHA), DD (Defense Department) Form 2795Figur  1
Pre-Deployment Health Assessment (PreDHA), DD (Defense Department) Form 2795. page 1. Responses sys-
tematically evaluated are outlined in red.
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Pre-Deployment Health Assessment (PreDHA), DD (Defense Department) Form 2795. page 2. Responses sys-
tematically evaluated are outlined in red.
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as Table 1.
Of the 615 deployed subjects with a recent mental health
disorder diagnosis, 17 (2.3%) had one or more inpatient
diagnoses, while 8 (1.3%) had one or more primary inpa-
tient diagnoses. All 615 had one or more outpatient diag-
noses, while 531 (86.3%) had one or more primary
outpatient diagnoses. The number of subjects with spe-
cific diagnoses, by ICD-9CM codes and type of diagnosis
are shown as Table 2.
Of the 8 deployed subjects with one or more primary
inpatient diagnoses, 3 were diagnosed with major depres-
sive disorders, 4 with adjustment disorder with depressed
mood, and 1 with post-traumatic stress disorder. Of the 8,
all (100%) had no prior deployments, and 5 (62.5%)
were female.
Pre-Deployment Health Assessments
Of the study cohort 11,179 (73.6%) subjects had at least
one PreDHA available for analysis that was completed
within the 90 days prior to deployment. Of these, a total
of 1,633 (14.6%) subjects completed multiple PreDHAs
during this period. The odds of a recent mental health dis-
order diagnosis were greater among those with one or
more PreDHA available as compared to those without a
PreDHA (OR = 1.12, 95% CI 0.93 - 1.35), although this
difference was not statistically significant (P = 0.242, χ2 =
1.37). Among subjects with at least one PreDHA available
for analysis and completed within the 90 days prior to
deployment, those with a recent mental health disorder
diagnosis also had greater odds of completing multiple
PreDHA in the 90 days prior to deployment (OR = 1.19,
95% CI 0.93 - 1.52) than of completing only one, but this
also did not reach statistical significance (P = 0.177, χ2 =
1.83).
Of the 8 deployed subjects with one or more primary
inpatient diagnoses, 7 had PreDHAs available, of which 6
(85.7%) answered in the affirmative to question #7, 2
(28.6%) in the affirmative to question #2, and none (0%)
in the affirmative to question #8.
PreDHA Responses and Test Characteristics
Among the 11,179 with one or more PreDHA completed
in the 90 days prior to deployment, 465 (4.2%) had one
or more recent mental health disorder diagnoses. Of the
465, 224 (48.2%) responded in the affirmative to ques-
tion #7.
Those with a recent mental health disorder diagnosis were
significantly more likely to answer question #7 in the
affirmative (OR = 41.8, 95% CI 33.4 - 52.3) than those
without (P < 0.001, χ2 = 2404). The odds ratio for ques-
tion #2 was considerably lower (OR = 2.88, 95% CI 2.30
- 3.60), as was that for question #8 (OR = 2.28, 95% CI
1.56 - 3.35), but both were statistically significant, (P <
0.001, χ2 = 93.1) and (P < 0.001, χ2 = 18.5) respectively.
The OR and NNS for each pertinent PreDHA question are
tabulated as Table 3.
Table 1: Demographics of the study cohort1 and those with a recent mental health disorder diagnosis2
Study cohort Subjects with a recent mental health disorder diagnosis
Number (Percentage) Number (Percentage)
Total 15195 (100) 615 (100)
Gender
Male 13816 (90.9) 506 (82.3)
Female 1379 (9.1) 109 (17.7)
Prior deployments
0 10180 (67.0) 362 (58.9)
1+ 5015 (33.0) 253 (41.1)
Military occupation
Combat 3810 (25.1) 125 (20.3)
Non-combat 11385 (74.9) 490 (79.7)
Age
18-19 503 (3.3) 22 (3.6)
20-29 9558 (62.9) 396 (64.4)
30-39 3737 (24.6) 151 (24.6)
40-49 1255 (8.3) 45 (7.3)
50+ 142 (0.9) 1 (0.2)
Note: Significant difference by gender (P < 0.001), prior deployment (P < 0.001), and military occupation (P = 0.006) by Chi-square.
1. Demographic characteristics as of the deployment date.
2. Record of one or more pertinent ICD-9CM diagnosis codes in the full year prior to date of deployment.Page 6 of 11
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Among all subjects completing one or more PreDHA in
the 90 days prior to deployment, a total of 31 subjects
(0.3%) received a pertinent referral. Among the 19
(61.2%) referred subjects indicating a positive response to
any of questions #7, #2 or #8, the odds of referral were
over 9 times higher (OR = 9.34, 95% CI 4.60 - 19.0) than
among those without any positive response (P < 0.001, χ2
= 54.2). Those endorsing question #7 in the affirmative
were considerably more likely to be referred (OR = 33.8,
95% CI 16.7 - 68.4) as compared to those who did not (P
< 0.001, χ2 = 231); as were those endorsing question #2
(OR = 4.89, 95% CI 2.37 - 10.1) as compared to those
who did not (P < 0.001, χ2 = 21.7). Those endorsing ques-
tion #8 in the affirmative were also more likely to be
referred (OR = 3.40, 95% CI 1.09 - 10.6) than those who
did not (P = 0.033, χ2 = 4.54). Among those who specifi-
cally answered question #7 in the negative, those with a
mental health disorder diagnosis were significantly more
likely to receive a referral (OR = 13.2, 95% CI 3.90 - 44.8)
than those without (P < 0.001, χ2 = 25.7).
Non-Deployable Final Medical Disposition
Among those who answered question #7 in the negative,
those with a recent mental health disorder diagnosis were
more likely to receive a final medical disposition of "not
Table 2: Numbers of subjects with a recent mental health disorder diagnosis1, by ICD-9-CM diagnosis code and encounter type
Number with any diagnosis
Diagnosis ICD-9CM diagnosis code Any Inpatient Outpatient
Primary Any Primary Any
Major depressive disorder 296.2-296.3 61 3 3 52 61
Adjustment disorder with depressed mood 309.0, 309.28 265 4 4 232 265
Prolonged depressive reaction 309.1 4 0 0 4 4
Dysthymic disorder 300.4 46 0 1 35 45
Depression 311 190 0 5 140 190
Cyclothymic disorder 301.13 2 0 0 2 2
Generalized anxiety disorder 300.02 19 0 0 15 19
Nonorganic psychoses and schizophrenia 295, 298 5 0 1 4 4
Bipolar and manic disorders 296.0-296.1, 296.4-296.8 14 0 0 12 14
Obsessive-compulsive disorder 300.3 8 0 0 7 8
Panic disorder, with or without agoraphobia 300.01, 300.21 19 0 0 13 19
Attention-deficit disorders, with or without hyperactivity 314.0 101 0 0 93 101
Dissociative, conversion and factitious disorders 300.1 7 0 0 6 7
Delusional disorders 297 1 0 0 1 1
Post-traumatic stress disorder 309.81 74 1 5 58 72
Any 615 8 17 531 615
1. Record of one or more pertinent ICD-9CM diagnosis codes in the full year prior to date of deployment.
Table 3: Test characteristics of PreDHA questions in identifying a recent mental health disorder diagnosis1 among subjects with 
available PreDHA2
Odds Ratio Number Needed to Screen
Subject self-reported data
"During the past year, have you sought counseling or care for your mental health?" 41.8 49.9
"Do you have any medical or dental problems?" 2.9 102.6
"Do you currently have any questions or concerns about your health?" 2.3 372.6
Positive response to any of the above 10.1 40.5
Provider-reported data
Referral indicated 17.1 859.9
Medical disposition "not deployable" 2.6 532.3
Positive response on one or more of the above 3.5 372.6
Any of the above
One or more of the above 9.5 39.6
1. Record of one or more pertinent ICD-9CM diagnosis codes in the full year prior to date of deployment.
2. Within 90 days prior to DTAS deployment date.Page 7 of 11
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3.56), but this difference was not statistically significant
(P = 0.178, χ2 = 1.82).
Among the study cohort, there were a total of 210 subjects
who were deployed when their most recent PreDHA was
annotated by the health care provider to say their final
medical disposition was "not deployable". Of these, 21
(10.0%) had a recent mental health disorder diagnosis;
none had an inpatient diagnosis, and 17 (81.0%) had one
or more primary outpatient diagnoses. Of the 21, 4 (19%)
had 2 prior deployments, 7 (33.3%) had 1 prior deploy-
ment, and the remainder had none. Of the 21, 5 (23.8%)
were female. Of the 21, 14 (66.7%) answered in the
affirmative to question 7, 12 (57.1%) to question 2, and
3 (14.3%) in the affirmative to question 8.
Discussion
This is the first study to assess the sensitivity and other test
characteristics of responses to PreDHA questions for iden-
tifying a recent mental health disorder diagnosis among
deployed U.S. service members. This study found a preva-
lence of recent mental health disorder diagnosis of 4.2%
among those with one or more PreDHA completed in the
90 days prior to deployment and available for analysis in
DMSS. Although this study found that subjects with a
recent mental health disorder diagnosis were significantly
more likely to answer pertinent questions on the PreDHA
in the affirmative, more than half of such subjects pro-
vided no indication of their diagnosis on their most recent
PreDHA.
This study found that the sensitivity of the question "dur-
ing the past year, have you sought counseling or care for your
mental health?" in identifying a recent mental health disor-
der diagnosis was only 48.2%. Subjects with a recent men-
tal health disorder diagnosis were over 41 times as likely
to answer this question in the affirmative as those with-
out, but this study also found that almost 50 subjects
needed to be screened with PreDHA to identify one sub-
ject with a recent mental health disorder diagnosis who
indicated such a response. Including affirmative responses
to additional relevant questions, including those inquir-
ing about current health concerns or problems did not
appreciably increase the sensitivity of self-reported data.
Furthermore, although subjects with a recent mental
health disorder diagnosis were over twice as likely to
endorse current medical or dental problems (OR = 2.88),
or to have questions or concerns about their health as
those without (OR = 2.28), only 23.4% of those with a
mental health disorder diagnosis endorsed current medi-
cal or dental problems, and only 6.5% endorsed any cur-
rent questions or concerns about their health.
These findings fit with those of other researchers, who
have noted among deploying and redeploying U.S. service
members perceptions of significant stigma associated
with mental health conditions [9-11], and a tendency
among U.S. service members towards underreporting as
well as a preference towards declining treatment. A major
study of U.S. service members preparing for deployment
to Iraq found among those who screened positive for
major depression, generalized anxiety, or PTSD, 86%
acknowledged a problem, but only 40% were interested in
receiving help [9]. Among a larger sample of service mem-
bers screening positive, a majority indicated perceived
barriers to receiving mental health care, including con-
cerns that others in their unit would lose confidence in
them, view them as being weak, or blame them for their
mental health problems [9]. The expression of these con-
cerns might be expected to increase in the context of mass-
screening programs such as PreDHA which are often con-
ducted at unit-level.
Perhaps not surprisingly, therefore, this study found a
very low rate of pertinent health care provider referrals.
Less than one-third of 1% of all subjects with an available
PreDHA (0.3%) received such a referral. Almost 860 sub-
jects had to be screened with PreDHA to result in a single
pertinent referral for a subject with a recent mental health
disorder diagnosis. Of subjects receiving such a referral,
approximately 6 in 10 (61.2%) had answered in the
affirmative to one or more pertinent question on their
most recent PreDHA, and those indicating a positive
response to such questions were over nine times (OR =
9.34) as likely to be referred as those who did not. Accord-
ing to current guidance [7], upon completion by the serv-
ice member, responses to PreDHA are to be immediately
reviewed by a "medic, nurse, medical technician or corps-
man", and any positive responses to (among others) ques-
tions 7, 2 and 8 "requires referral to a trained health care
provider (physician, physician assistant, nurse practitioner,
advanced practice nurse, independent duty corpsman, inde-
pendent duty medical technician, or Special Forces medical ser-
geant)" [7]. Existing DoD guidance is not clear as to
whether this referral requires appropriate additional
annotation by the trained health care provider on the
PreDHA, or merely requires the PreDHA to be reviewed
and certified by such a provider.
Of note in this analysis, subjects who had a recent mental
health disorder diagnosis but denied having such a his-
tory were not statistically more likely to be identified by
the provider as "not deployable" than those without such a
history, which suggests that these subjects might have
been able to successfully conceal or minimize a poten-
tially disqualifying condition. Whether the 21 "not deploy-
able" subjects with a mental health disorder diagnosis
were appropriately deployed in accordance with current
DoD guidance and regulations is not clear by this study's
methodology. Existing DoD instructions [7] describe only
the manner in which PreDHAs are to be completed, butPage 8 of 11
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provided responses constitutes a disqualification for
deployment; nor do they formalize a mechanism for
ensuring that service members flagged by the provider as
"not deployable", in fact, are not deployed. A recent policy
memorandum drafted in response to Congressional con-
cerns [26]"provides guidance on deployment... for military per-
sonnel who experience psychiatric disorders" and states that
"diagnosed conditions that are not amenable or anticipated not
amenable to treatment and restoration to full functioning
within one year of treatment should generally be considered
unfitting...." The memorandum specifically states that
"psychotic and bipolar disorders are considered disqualifying for
deployment". This study found evidence of 5 subjects with
diagnoses of psychoses and 14 subjects with diagnoses of
bipolar and manic disorder. Whether these subjects were
appropriately deployed is also not clear by this study's
methodology.
This study has a number of important limitations that
require the results to be interpreted in context. Most sig-
nificantly, this study included only service members who
were identified on official rosters as being deployed; not
the larger cohort of service members who were adminis-
tered PreDHA in anticipation of deployment. Limitations
in data available within the DMSS precluded accurately
identifying this cohort; future studies using alternate
methodologies might assess the number of service mem-
bers who may have been identified as "not deployable" and
who did not subsequently deploy.
This study, as with previous research on deployment-
related mental health issues [12,27], relied upon medical
surveillance data in the DMSS to identify the presence of
pertinent mental health disorder diagnoses. The strengths
and limitations of this data have been previously
described [12], although research has demonstrated good
correlation between ICD-9CM coded mental health disor-
der diagnoses and evidence of psychoactive pharmaco-
therapy [28], confirming the utility of surveillance
databases in identifying functional psychiatric morbidity.
This study examined only records of ICD-9CM diagnostic
codes corresponding to pertinent mental health disorders,
and did not assess ICD-9CM "V-coded" visits for coun-
seling not associated with a formal diagnosis [29], nor vis-
its to social workers, chaplains, and other counselors
practicing outside of administrative systems whose data is
captured by the DMSS. Including such data as evidence of
a recent mental health disorder diagnosis might have
improved the validity and test characteristics of the
PreDHA. For example, making the assumption that all
subjects without evidence of diagnosis who had answered
question #7 in the affirmative, in fact, had received some
form of counseling or care for a mental health disorder,
independent of documented diagnosis, would have
increased the sensitivity of the question, as written, to
65.6% and decreased the NNS to 24.5 (data not shown).
This study included ADHD in the definition of a mental
health disorder diagnosis. Although a remote history of
ADHD may not always be considered problematic, in U.S.
military settings a recent active diagnosis of ADHD
remains highly relevant. A recent study of health care
operations in Iraq [30] confirms that " [d]eployment of sol-
diers with chronic mental health disorders such as anxiety,
attention deficit disorder, and depression is problematic..." Fur-
thermore, the previously mentioned policy memoran-
dum [26] states "[p]sychotropics clinically and operationally
problematic during deployments include... stimulants", which
are commonly prescribed to treat ADHD. In the present
analysis, of the 615 subjects with a recent mental health
disorder diagnosis, 101 subjects (16.4%) were identified
with a recent diagnosis of attention-deficit disorders, with
or without hyperactivity. Of these, the vast majority
(92%) received primary outpatient diagnosis, highly sug-
gestive of active disorder. Furthermore, there is a high
prevalence of treated attention-deficit disorder conditions
among deployed personnel as suggested by a recent pub-
lished study [20], in which 78 of 11,725 deployed sub-
jects (0.67%) had been prescribed a pharmacologic
treatment for ADHD prior to deployment; highly compa-
rable to the 101 of 15,195 (0.66%) diagnosed with an
attention-deficit spectrum diagnosis in this present analy-
sis.
As this analysis examined electronic medical records only
for evidence of a recent diagnosis, remote histories not
requiring continued treatment would not necessarily have
been identified. Additionally, while ADHD is recognized
professionally as a mental health diagnosis, service mem-
bers who consider their condition as other than a "mental
health issue or problem" may have responded in the nega-
tive to the question on the PreDHA despite recent diagno-
sis. Future analyses should be performed to address to
what extent perception of this condition, and other condi-
tions, could have influenced the results of this study.
This study examined only PreDHA data successfully inte-
grated and available for analysis in the DMSS. Of the
study cohort, a total of 4,016 subjects (26.4%) had no
PreDHA available within the 90 days prior to deploy-
ment. Of the subjects without an available PreDHA, 150
(3.7%) had a mental health diagnosis. The methodology
of this study was unable to determine whether a PreDHA
was actually administered to these subjects. Although
completion of the PreDHA is mandatory, no formal sys-
tem exists to validate the correct transmission of PreDHA
data from military service-specific sources to AFHSC, nor
to provide timely confirmation to the service member, hisPage 9 of 11
(page number not for citation purposes)
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successful integration of the service member's data into
the DMSS prior to deployment.
Independent of these limitations, this study demonstrates
that the subject-reported data collected during the
PreDHA process is of questionable validity. Existing pol-
icy [26] states that "it is the responsibility of the Service mem-
ber to report past or current physical or mental health
conditions or concerns and associated treatments". The results
of this study provide strong evidence that relying on self-
report alone may be insufficient policy for screening for
disqualifying or significant mental health conditions.
These results support the recent conclusions of the
Department of Defense Task Force on Mental Health, a
special body established at the direction of Congress to
"examine matters relating to mental health and the Armed
Forces". In the Task Force's final report, it was noted that
its members "were told on multiple site visits that the validity
of the Pre-Deployment Health Assessment suffers because serv-
ice members underreport their mental health concerns..." [31]
In the policy memorandum announcing the introduction
of the PreDHA in 1998 [3], it was noted that the objective
of the assessments was merely to provide "quick confirma-
tion and documentation of a service member's health readiness
for deployment or redeployment and to determine if there is a
need for a clinician's evaluation before deployment or redeploy-
ment. Future revisions of deployment health assessments shall
require pilot testing and question validation before being put
into use" [3]. Furthermore, this memorandum stated that
"deployment-related mental health screening will be addressed
in a separate policy memorandum". Since this original
announcement released over ten years ago, no such policy
memorandum has been issued, and no formal validation
of the PreDHA has been published or undertaken.
Conclusion
This study demonstrates that self-report by PreDHA has
low validity in identifying members of the U.S. military
with a recent mental health disorder diagnosis. In light of
this study's findings and in consonance with prior recom-
mendations to improve the quality of mental health care
provided to U.S. military service members, consideration
should be given to complementing the PreDHA with a
validated mental health screening instrument of higher
sensitivity [32]. The development of electronic decision-
support systems which automatically screen electronic
health records, including ICD-9CM diagnosis and phar-
macy data, to identify high-risk service members may
prove a valuable component of improved pre-deploy-
ment processing [33]. Such systems have been proposed
previously as a means of improving the safety of prescrib-
ing and dispensing of mefloquine, which shares with pre-
deployment screening the requirement to accurately iden-
tify a history of recent mental health diagnosis [20].
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